I joined NDORMS in 2017 as a member of the Musculoskeletal Pharmacoepidemiology group in order to enter a DPhil programme at the beginning of the academic year 2017/2018. My research is going to be focused on method development for the risk-benefit evaluation of surgical procedures.
Previously I worked at the Department of Clinical Epidemiology of the Aarhus University, collaborated with the Department of Medical Informatics of the Erasmus Medical Center and studied medicine and mathematics in Budapest.
Rates of Community-based Antibiotic Prescriptions and Hospital-treated Infections in Individuals With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study, 2004-2012.
Mor A. et al, (2016), Clin Infect Dis, 63, 501 - 511
Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.
Jensen LO. et al, (2016), Circ Cardiovasc Interv, 9
Association of parental history of type 2 diabetes with age, lifestyle, anthropometric factors, and clinical severity at type 2 diabetes diagnosis: results from the DD2 study.
Svensson E. et al, (2016), Diabetes Metab Res Rev, 32, 308 - 315
Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.
Jensen LO. et al, (2016), J Am Coll Cardiol, 67, 751 - 762
Implementation of interval walking training in patients with type 2 diabetes in Denmark: rationale, design, and baseline characteristics.
Ried-Larsen M. et al, (2016), Clin Epidemiol, 8, 201 - 209